Poxel
1 known investors
Poxel develops small-molecule therapeutics for metabolic diseases, including a marketed type 2 diabetes product in Japan and mid-stage candidates targeting NASH and rare metabolic conditions.
BiotechHealthtechMedical Devices
1 known investors
Poxel develops small-molecule therapeutics for metabolic diseases, including a marketed type 2 diabetes product in Japan and mid-stage candidates targeting NASH and rare metabolic conditions.